HEART FAILURE: BIOMARKERS OF DIAGNOSIS AND PROGNOSIS

HEART FAILURE: BIOMARKERS OF DIAGNOSIS AND PROGNOSIS

Heart Failure remains a common presentation in the emergency department. For the emergency physician clarifying the course of the universal complaint, shortness of breath, requires excellent clinical acumen combined with a clear understanding of the laboratory tests available to distinguish Heart Failure from other causes of dyspnea. Dr. Frank Peacock of the Cleveland Clinic authors an excellent discussion of the scientific basis for the use of the natriuretic peptide biomarkers in heart failure including future markers currently being investigated.

Read More

USE OF NT-PROBNP IN THE EMERGENCY DEPARTMENT EVALUATION OF SHORTNESS OF BREATH: IMPLICATIONS FOR CLINICAL PRACTICE

USE OF NT-PROBNP IN THE EMERGENCY DEPARTMENT EVALUATION OF SHORTNESS OF BREATH: IMPLICATIONS FOR CLINICAL PRACTICE

In this EMCREG-International newsletter, Sean P. Collins, MD, Assistant Professor of Emergency Medicine at University of Cincinnati, OH discusses incidence of heart failure has been rising over the last decade as more patients survive significant myocardial infarction, as well as other diseases which compromise the heart. All clinicians who care for these patients must be aware of the many diagnostic and therapeutic approaches to these often critically-ill patients. NT-proBNP provides an important diagnostic and prognostic test for these heart failure patients.

Read More